fbpx

Insights on the Rapid Microbiology Testing Global Market to 2027 – Featuring Abbott, Bio-Rad Laboratories and Merck Among Others

Insights on the Rapid Microbiology Testing Global Market to 2027 - Featuring Abbott, Bio-Rad Laboratories and Merck Among Others
Share on facebook
Share on twitter
Share on pinterest

DUBLIN, May 28, 2021 /PRNewswire/ — The “Rapid Microbiology Testing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Rapid Microbiology Testing estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027.

Instruments, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Kits segment is readjusted to a revised 7.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 10.4% CAGR

The Rapid Microbiology Testing market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Consumables Segment to Record 6.8% CAGR

In the global Consumables segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$644.9 Million in the year 2020 will reach a projected size of US$988.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$849.4 Million by the year 2027, while Latin America will expand at a 8.1% CAGR through the analysis period.

Select Competitors (Total 32 Featured):

Abbott
BD
bioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Gen-Probe Inc.
Merck KGaA
Quidel Corporation
Siemens Healthcare GmbH
Sysmex
Thermo-Fisher Scientific Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA

IV. COMPETITION

Total Companies Profiled: 32

For more information about this report visit https://www.researchandmarkets.com/r/skx6tw

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Share this post with your friends

Share on facebook
Share on google
Share on twitter
Share on linkedin

Leave a Reply

Do You Want To Boost Your Business?

Send Me Your Press Release and I'll Blast it Out To The World -- It's Free

%d bloggers like this: